RENOVA BIOMED
Renova Biomed is a privately held Italian medical device manufacturer, founded in 2000 and headquartered in Rome, that produces products for pain therapy, plastic surgery, and regenerative medicine for clinical specialty customers.
- Company typePrivate
- Founded2000
- HeadquartersRome, Italy
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What RENOVA BIOMED does
Renova Biomed is an Italian medical device manufacturer headquartered in Rome, Italy. Founded in 2000, the company produces products spanning three clinical categories: pain therapy, plastic surgery, and regenerative medicine. The firm operates as a private, for-profit entity with no public IPO or funding history reflected in the available sources. Its functional orientation — manufacturing devices and consumables for specialty clinical use rather than consumer products — implies distribution through medical channels (hospitals, specialty clinics, plastic surgeons, pain management physicians) under appropriate medical-device regulatory regimes (e.g., EU MDR/IVDR, CE marking, ISO 13485 quality system), though no specific clearances are enumerated in the available data.
The current publicly accessible website returns only a security verification/loader screen and provides no product catalog, no leadership disclosure, no pricing, no certification list, no partnership disclosures, and no investor information. The input aggregation therefore supports only the most basic firmographic profile: a long-tenured (25 years) Italian medical device company with a narrow but clinically diversified product focus in pain management, aesthetic/reconstructive surgery, and regenerative medicine. No information is available on manufacturing footprint, R&D pipeline, distribution partners, geographic markets served, or technology stack.
The business model cannot be precisely characterized from the data provided. There is no pricing detail, no GTM motion documented, no customer logos, no segment mix, no headcount, and no revenue figures. For investment-analytic purposes, Renova Biomed is best characterized as a data-thin, privately held, niche European medical device manufacturer whose category reach (pain, plastic surgery, regenerative medicine) is suggestive of specialty-clinic distribution but whose actual scale, economics, and strategic direction require primary-source diligence before any conclusion can be drawn.
RENOVA BIOMED firmographics
Firmographics- Name
- RENOVA BIOMED
- Website
- https://renovabiomed.it
- Company type
- Private
- Founded year
- 2000
- Headcount range
- 1–10 employees
- Short description
- Renova Biomed is a privately held Italian medical device manufacturer, founded in 2000 and headquartered in Rome, that produces products for pain therapy, plastic surgery, and regenerative medicine for clinical specialty customers.
- Ownership category
- akta.pro rank
RENOVA BIOMED industry classification
Industry- Product category
- Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Biological Product (except Diagnostic) Manufacturing (325414), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)
- akta.pro secondary industries
- Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)
Keywords
Where RENOVA BIOMED is headquartered
LocationHeadquarters
- HQ city
- Rome
- HQ country
- Italy
- HQ region
- Europe
Markets served
RENOVA BIOMED business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
RENOVA BIOMED product offering
Product offeringCore offering
Renova Biomed is a manufacturer of medical products serving three therapeutic segments: pain therapy, plastic surgery, and regenerative medicine. The company produces physical medical devices and supplies used by healthcare professionals and medical facilities in patient treatment and surgical procedures.
Product overview
No product information available from source data. The source website (http://renovabiomed.it/) returned only a loading/verification page stating 'One moment, please...' with no substantive company, product, or service content.
Differentiator
Problem solved
Functional benefit
Products and services
- Pain therapy medical products Medical products manufactured for pain therapy applications, intended for healthcare providers treating patients with pain conditions.
- Plastic surgery medical products Medical products manufactured for plastic surgery procedures, supplied to plastic surgeons and surgical facilities.
- Regenerative medicine medical products Medical products manufactured for regenerative medicine applications, supporting biological healing and tissue repair treatments.
Companies that use RENOVA BIOMED
Customer profileIdeal customer profiles1 record
RENOVA BIOMED technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
RENOVA BIOMED competitors and assessment
Company assessmentDirect peers
- Organogenesis: Commercializes regenerative medicine products including skin substitutes and wound care biologics used in plastic surgery and chronic wound management. Direct overlap with RENOVA BIOMED's plastic surgery and regenerative medicine verticals.
- MiMedx: Specializes in regenerative medicine products derived from placental tissue for wound healing, surgical recovery, and pain management. Closely aligned with RENOVA BIOMED's regenerative medicine and pain therapy focus.
- Vericel: Develops and commercializes advanced cell therapies and regenerative medicine products for cartilage repair and burns/wounds, directly mirroring RENOVA BIOMED's regenerative and plastic surgery positioning.
- RTI Surgical: Manufactures regenerative surgical implants including biologic scaffolds for orthopedic, spine, and sports medicine - overlapping with pain therapy and regenerative medicine applications.
Broad incumbents
- Stryker: Large diversified medical device firm with orthopedic, pain management, and surgical equipment franchises - a broad incumbent overlapping in pain therapy devices and regenerative surgical products.
- Smith & Nephew: Global medical device manufacturer with significant wound management, regenerative medicine, and orthopedic/pain therapy franchises. Directly comparable as a multi-vertical regenerative and surgical products manufacturer serving hospitals and clinics.
- Integra LifeSciences: Broad medical technology company with regenerative tissue technologies (DuraGen, Integra Dermal Regeneration Template) used in plastic/reconstructive surgery and wound care. Comparable in regenerative and surgical appliance manufacturing.
Emerging players
- Collagen Solutions: Supplies medical-grade collagen and biomaterials used in regenerative medicine, wound healing, and tissue engineering applications - adjacent supplier-level peer in the regenerative biologics value chain.
- MediWound: Specialty biologics company focused on enzymatic wound debridement and regenerative skin therapies for burn and chronic wound care - relevant peer in plastic surgery/reconstructive regenerative wound products.
Regional players
- Finceramica: Italian medical device company developing regenerative bone and cartilage substitutes and tissue engineering products - comparable European/Italian peer in regenerative medicine manufacturing.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat1 record
Key risks5 records
Key highlights4 records
Customer concentration
RENOVA BIOMED social profiles
Digital presenceRENOVA BIOMED financial estimates
Financial estimateRevenue estimate
Valuation estimate
RENOVA BIOMED leadership team
Management profileNumber of profiles
RENOVA BIOMED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RENOVA BIOMED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RENOVA BIOMED
What does RENOVA BIOMED do?
Renova Biomed is a manufacturer of medical products serving three therapeutic segments: pain therapy, plastic surgery, and regenerative medicine. The company produces physical medical devices and supplies used by healthcare professionals and medical facilities in patient treatment and surgical procedures.
When was RENOVA BIOMED founded?
RENOVA BIOMED was founded in 2000. It employs 1 to 10 people.
Where is RENOVA BIOMED based?
RENOVA BIOMED is headquartered in Rome, Italy, in the Europe region.
Who are RENOVA BIOMED's main competitors?
Direct peers on record are Organogenesis, MiMedx, Vericel and RTI Surgical. Broad incumbents are Stryker, Smith & Nephew and Integra LifeSciences. Emerging players are Collagen Solutions and MediWound. Finceramica is listed as a regional player.
Does RENOVA BIOMED have an API?
No public API is recorded for RENOVA BIOMED.
What industry is RENOVA BIOMED in?
RENOVA BIOMED's product category is Medical Devices. Its primary akta.pro industry code is HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 339113 and its SIC code is 3841.